A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development

Medicare Part D—A Roundtable Discussion of Current Issues and Trends

(2016) Donald Balfour et al.   JOURNAL OF MANAGED CARE PHARMACY

Ongoing pharmaceutical reforms in France

(2013) Catherine Sermet et al.   Applied Health Economics and Health Policy

National Drug Policies to Local Formulary Decisions in Thailand, China, and Australia: Drug Listing Changes and Opportunities

(2012) Worasuda Yoongthong et al.   VALUE IN HEALTH

Drug Reimbursement Decision-Making in Thailand, China, and South Korea

(2012) Surachat Ngorsuraches et al.   VALUE IN HEALTH

Determinants of generic drug substitution in Switzerland

(2011) Anne Decollogny et al.   BMC HEALTH SERVICES RESEARCH

Health Economics and Health Technology Assessment: Perspectives from Australia and New Zealand

(2011) Stephen Streat et al.   CRITICAL CARE CLINICS

Evaluation on the first 2 years of the positive list system in South Korea

(2011) Sung Eun Park et al.   HEALTH POLICY

Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010

(2011) Jamie R. Daw et al.   HEALTH POLICY

Full Coverage for Preventive Medications after Myocardial Infarction

(2011) Niteesh K. Choudhry et al.   NEW ENGLAND JOURNAL OF MEDICINE

The impact of copayments and safety nets on PBS expenditure

(2010) Kim Sweeny   Australian Health Review

The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries

(2010) Wija Oortwijn et al.   HEALTH POLICY

Value-Based Approaches to Healthcare Systems and Pharmacoeconomics Requirements in Asia

(2010) Isao Kamae   PHARMACOECONOMICS

Acceptable Incremental Cost Effectiveness Ratio for Use of New Drugs, Cases in Statin Therapies

(2010) Susumu NAKAO et al.   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

Recent developments in pharmacoeconomic evaluation in Ireland

(2010) Lesley Tilson et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Public drug expenditure in the Republic of Ireland

(2010) Michael Barry et al.   Expert Review of Pharmacoeconomics & Outcomes Research

The cost effectiveness of a quadrivalent human papillomavirus vaccine (6/11/16/18) in Hungary

(2010) Erik J. Dasbach et al.   JOURNAL OF MEDICAL ECONOMICS

Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill

(2009) Matthew D. Solomon et al.   ARCHIVES OF INTERNAL MEDICINE

Pharmacoeconomics: NICE's approach to decision-making

(2009) Michael Rawlins et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Impact of a Prescription Copayment Increase on Lipid-Lowering Medication Adherence in Veterans

(2009) Jalpa A. Doshi et al.   CIRCULATION

Austria: History of health technology assessment during the past 20 years

(2009) Claudia Wild   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

The process of updating the National List of Health Services in Israel: Is it legitimate? Is it fair?

(2009) Dan Greenberg et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Effects of Prescription Coinsurance and Income-Based Deductibles on Net Health Plan Spending for Older Users of Inhaled Medications

(2009) Colin R. Dormuth et al.   MEDICAL CARE

Health Technology Assessment: A Perspective from Germany

(2009) Frank-Ulrich Fricke et al.   VALUE IN HEALTH

Health Technology Assessment in Canada: 20 Years Strong?

(2009) Devidas Menon et al.   VALUE IN HEALTH

Evidence-Based Decision-Making on Medical Technologies in China, Japan, and Singapore

(2009) Gordon G. Liu et al.   VALUE IN HEALTH

Evidence-Based Decision-Making in Asia-Pacific with Rapidly Changing Health-Care Systems: Thailand, South Korea, and Taiwan

(2009) Thidaporn Jirawattanapisal et al.   VALUE IN HEALTH

Pharmacoeconomic Guidelines and Their Implementation in the Positive List System in South Korea

(2009) Eun Young Bae et al.   VALUE IN HEALTH

Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures

(2008) V. Demers et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Economic Evaluation And Pharmaceutical Reimbursement Reform In South Korea’s National Health Insurance

(2008) Bong-min Yang et al.   HEALTH AFFAIRS

The impact of co-payment increases on dispensings of government-subsidised medicines in Australia

(2008) Anna Hynd et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests

(2008) Irina Cleemput et al.   VALUE IN HEALTH

Insight into recent reforms and initiatives in Austria: implications for key stakeholders

(2008) Brian Godman et al.   Expert Review of Pharmacoeconomics & Outcomes Research